BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11595609)

  • 1. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
    Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
    Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
    Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
    J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
    Pomer S; Elert O; Sarai K; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
    Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.
    Levine TB; Levine AB; Elliott WG; Narins B; Stomel RJ
    Clin Cardiol; 2001 Mar; 24(3):231-6. PubMed ID: 11288970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
    Mikulic E; Cohn JN; Franciosa JA
    Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure.
    Coddens J; Delooft T; Vandenbroucke G
    J Cardiothorac Vasc Anesth; 1993 Jun; 7(3):321-5. PubMed ID: 8518380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
    Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
    Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
    Applefeld MM; Newman KA; Sutton FJ; Reed WP; Roffman DS; Talesnick BS; Grove WR
    Am Heart J; 1987 Sep; 114(3):589-95. PubMed ID: 3630900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone attenuates the proarrhythmic effects of dobutamine in patients with advanced congestive heart failure.
    Tsagalou EP; Gounopoulos P; Terrovitis JV; Drakos SG; Katsaros FT; Kaldara EE; Alexopoulos GP; Anastasiou-Nana MI
    Hellenic J Cardiol; 2009; 50(3):193-8. PubMed ID: 19465360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
    Nanas JN; Tsagalou EP; Kanakakis J; Nanas SN; Terrovitis JV; Moon T; Anastasiou-Nana MI
    Chest; 2004 Apr; 125(4):1198-204. PubMed ID: 15078725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
    Massie BM; Cornyn J; Topic N; Loge D; Podolin RA
    Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
    Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
    Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dopamine and dobutamine therapy during intraaortic balloon pumping for the treatment of postcardiotomy low-output syndrome.
    Sterling RP; Taegtmeyer H; Turner SA; Walker WE; Cooley DA
    Ann Thorac Surg; 1984 Jul; 38(1):37-41. PubMed ID: 6610395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.